您的瀏覽器不支援JavaScript功能,您可以開啟JavaScript

About CDC

|

NEWS

|

Health Topics

|

Programs & Campaigns

|

International Cooperation

|

Statistics & Analysis

|

Publication

|

Application Form

|

NHCC

:::

Original-Article

Taiwan SARS Experience and the Challenge for Future Outbreak of H5N1 Influenza( 2013-01-25 )


Ih-Jen Su

網路分享Share-另開視窗

2008/4   Volume 24    Number 4 Ih-Jen Su

Taiwan suffered severely from the outbreak of severe acute respiratory syndrome (SARS) in 2003. The lack of experience, poor coordination of commanding system, inadequate scientific capability, poor infection control together account for the final outcome of SARS 2003. The lessons learned from SARS, however, drive Taiwan to prepare for the coming outbreak of H5N1 pandemic influenza and other emerging infectious diseases. Several control measures were activated in the post-SARS period including central command and governance structure re-organization, improved scientific capability and laboratory diagnostics, surveillance and real-time reporting, law revision and enforcement. Furthermore, the government implemented a policy to self-manufacture anti-virals and vaccine for influenza and H5N1. The above measures proved to be effective for the control of dengue infection, seasonal influenza, and enteroviruses in the post-SARS period. The measure most worthwhile to share with the world is the stockpile of 2.3 million pills of of anti-virals-Tamiflu on February 2004. The control policy of ILI illness by antivirals proves to be effective in institutional outbreaks of seasonal influenza. This strategy can be applied to the control of H5N1 pandemic flu. Taiwan paid the painful price for SARS and we should benefit from the lessons in the coming outbreak of H5N1 influenza.



  • Last modified at 2013-01-25
  • Data from Division of Planning and Coordination
【Taiwan Epidemiology Bulletin GPN : 4909902427 ISSN 2078-4252】